We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Keeps Avandia on the Market, But With Severe Restrictions
FDA Keeps Avandia on the Market, But With Severe Restrictions
September 23, 2010
The FDA has allowed GlaxoSmithKline’s (GSK) diabetes drug Avandia to remain on the market, but with severe restrictions on its access.